Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Thrombin
100%
Coagulating Agent
99%
Blood Clotting Factor 7
79%
Thalassemia
79%
Thromboplastin
57%
Hemoglobins
44%
Blood Clotting Factor 9
39%
Nitrite
39%
Site-Directed Mutagenesis
39%
Vein Thrombosis
39%
Antithrombin
39%
Complement Component C1s Inhibitor
39%
Heparin
39%
Rabies
39%
Low Density Lipoprotein
39%
Gene Delivery
39%
High Density Lipoprotein
39%
Tissue Factor Pathway Inhibitor
39%
Nitric Oxide
34%
F Factor
32%
Protein S
26%
Vaccination
23%
Haemophilia B
19%
Thrombogenicity
19%
Mutagenesis
14%
Normal Human
14%
Angioneurotic Edema
14%
Hypercoagulability
13%
Antigen
13%
Activated Protein C
13%
Oral Contraceptive Agent
13%
Bleeding
12%
Blood Stasis
12%
Lipid
10%
High Density Lipoprotein 2
9%
High Density Lipoprotein 3
9%
Hemostatic Agent
9%
Clotting Time
9%
Fibrin
9%
TBARS
9%
Procoagulant
9%
Cholesterol
9%
Alkadiene
9%
Haemophilia A
9%
Blood Clotting Factor
9%
Venous Thromboembolism
9%
Clinical Trial
7%
Infection
7%
Rabies Vaccine
7%
Activated Protein C Resistance
6%
Biochemistry, Genetics and Molecular Biology
Deficiency
89%
Factor VII
79%
Exosite
69%
Thrombin
69%
Wild Type
49%
Blood Plasma
45%
Antithrombin
42%
Heparin
39%
Factor IX
39%
C1-Inhibitor
39%
Hemoglobins
39%
Nitric Oxide
39%
Hepatocyte
39%
Phlebothrombosis
39%
Thromboplastin
27%
Hereditary Angioedema
14%
Hemoglobin Blood Level
13%
Secretion (Process)
9%
Upregulation
9%
Unfolded Protein Response
9%
Zymogen
9%
Tissue Factor Pathway Inhibitor
9%
Haemophilia B
9%
Anticoagulation
9%
Platelet-Poor Plasma
9%
Coagulation System
7%
Stem Cell
7%
Lipid Peroxidation
6%
Chemoluminescence
6%
Lactate Dehydrogenase
6%
Oxidative Stress
6%
Blood Coagulation Factor
6%
Medicine and Dentistry
Venous Thromboembolism
44%
Systematic Review
39%
Rabies
39%
Protein C
39%
Evans Syndrome
39%
Neck
39%
Protein C Deficiency
39%
Molecular Pathology
39%
Meta-Analysis
39%
Analgesia
39%
Capsaicin
39%
Vanilloid Receptor 1
22%
Pridinol
14%
Secretion (Process)
14%
Nociception
11%
Gene Expression
9%
Immunofluorescence
9%
Thromboembolism
9%
Endoplasmic Reticulum Stress
9%
Pediatrics Patient
9%
Post-Exposure Prophylaxis
7%
Rabies Vaccine
7%
Clinical Trial
7%
Health Care Cost
7%
Pre-Exposure Prophylaxis
7%
High Risk Population
7%
Infection
7%
Cohort Studies
6%
Odds Ratio
6%
Hazard Ratio
6%
Standardized Incidence Ratio
6%
Observational Study
6%
Cross Sectional Study
6%
Side Effect
5%
Monotherapy
5%
Adverse Event
5%
Contralateral Side
5%
Contact Dermatitis
5%
Topical Anesthesia
5%
Heat Sensation
5%
Refractory Period
5%
Visual Analog Scale
5%